Premium Essay

Medicines Co Marketing

In:

Submitted By guy10023
Words 763
Pages 4
The Medicines Company Case Write-Up: Terence Cho, Felipe Duarte, Aleks Loiko, Robert Shaw, and James Wang
Section 4, Group 10
Medicines Company’s drug, Angiomax, outperforms Heparin, but incurs significantly higher costs to produce, making the drug difficult to attractively price. This difficulty in pricing stems from a poor positioning strategy for Angiomax which does not maximize the perceived value (PV) that the drug provides to its key customer segments. Therefore, Medicines Co., must develop a positioning strategy that maximizes the perceived value of Angiomax. Medicines Co. must first determine the critical characteristics its key customer segments (doctors, hospital administrators, and pharmacists) value in an anticoagulant (Appendix A). Medicines Co. should then develop a positioning statement that highlights Angiomax’s strengths for its most compatible customer segment – doctors. The positioning statement for doctors would be “Angiomax outperforms Heparin in high-risk patients resulting in significantly fewer complications while performing angioplasty procedures”. The focus should be on doctors because of the high overlap between Angiomax’s benefits and doctors’ values in an anticoagulant. Additionally, by providing doctors with information (Appendix B) that quantifies the cost savings from reduced complications in high-risk patients, Medicines Co. bridges the gap between the true economic value (TEV) and the PV that doctors have for Angiomax.
This solution is the best because it focuses on what doctors’ value in an anticoagulant. From the case, we know that doctors are key customers for adopting new drugs and that hospital administrators, who have similar preferences for an anticoagulant, are difficult to reach directly (Appendix A). By focusing on the value offered to doctors, we are raising doctors’ PV for Angiomax. We are assuming this PV

Similar Documents

Premium Essay

Res 351

...purpose of making money. Not only do the drug companies practice unethical research studies, but they also spend more money pushing the products then they do for the research of the drug. Two such companies have been accused, trialed and charged for smudging results and falsifying findings for lucrative benefits. Merck and Co. was accused of several unethical acts. Merck & Co. marketed a drug called Vioxx. The drug was said to have less gastrointestinal problems than its counterpart competition – naproxen. However, Vioxx had considerably more side effects including; heart attacks and strokes (Vershoor,C.C., 2006). The drugs were pulled from the market in September, 2004, but not before over 100 million prescriptions were filled. Merck & Co. (Gardinar, H. 2009). was also accused of misrepresentation or concealing of study results to doctors. The New England Journal of Medicine reported that previous studies of three patients had been withheld. In these three particular studies the patients all suffered heart attacks when taking Vioxx. Sales reps for Merck & Co. were trained to use subliminal selling tactics. Additionally, Merck & Co. only chose biased speakers of their products at educational events....

Words: 875 - Pages: 4

Premium Essay

The Pharmaceutcal Industry

...sole purpose of making money. Not only do the drug companies practice unethical research studies, but they also spend more money pushing the products then they do for the research of the drug. Two such companies have been accused, trialed and charged for smudging results and falsifying findings for lucrative benefits. Merck and Co. was accused of several unethical acts. Merck & Co. marketed a drug called Vioxx. The drug was said to have less gastrointestinal problems than its counterpart competition – naproxen. However, Vioxx had considerably more side effects including; heart attacks and strokes (Vershoor,C.C., 2006). The drugs were pulled from the market in September, 2004, but not before over 100 million prescriptions were filled. Merck & Co. (Gardinar, H. 2009). Was also accused of misrepresentation or concealing of study results to doctors. The New England Journal of Medicine reported that previous studies of three patients had been withheld. In these three particular studies the patients all suffered heart attacks when taking Vioxx. Sales reps for Merck & Co. were trained to use subliminal selling tactics. Additionally, Merck & Co. only chose...

Words: 1123 - Pages: 5

Premium Essay

Mba(Ha)- Syallabus

... • Changing pattern of diseases • Concept of health indicators Preliminary Human anatomy and Physiology • Basic concepts of human anatomy • Basic concepts of human physiology Suggested Reading: Human Anatomy- Prof. Samar Mitra Human Anatomy- Prof. A. K. Dutta Text Book of Human Physiology- Dr. C. C. Chatterjee Common Pathological Conditions • Basic concepts of pathogenesis of common diseases • Basic concepts of interpretation of investigations reports Suggested Reading: Robbin’s Textbook of Pathology – Robbin, Cotran, Kumar Textbook of Microbiology – Ananantanarayan & Paniker Basic concepts of Pharmacology: Commonly used Medicine in a hospital, Narcotic drugs, use and abuse of drugs. Dispensing of medicine, Drugs store, drug stock / purchase of medicine, oxygen, I/V Fluid, Chemicals etc. Suggested Reading: Textbook of Pharmacology: Dr. K. D. Tripathi PAPER – 2: Hospital Based Healthcare & Its changing scenario-Code MHA 102 Overview of Hospital • Concept of Modern Hospital & Privatization in Health Sector • Public Sector Hospitals and Level of care / offered facilities • Effects of Globalization in Health care • Concept of Corporate Hospital in developing countries • Infrastructure and lay out of an ideal corporate hospital • Functioning of modern hospitals & changing need of patients • Hospitality in Hospital Care • Invasive and non-invasive diagnostic facilities in modern hospital ...

Words: 3303 - Pages: 14

Premium Essay

Merck Business Analysis

...made a difference between the product cost and disposable income of consumers. According to NASDAQ (2011),“ Global pharmaceutical market sales are expected to grow at a 4-7% through the year 2013 largely being driven by the growing access to health care in emerging economic regions” (para. 2-5). Short-term growth within this area is stimulated by the United States market, as it continues to be the largest pharmaceutical market in the world. A focal point on research and development in special drugs and generic drugs will remain a strong means to meet 2011 goals of earning $315 billion dollar in sales within the United States. Strategies Merck & Co., Inc. has outlined its long-term strategic goals in how the company devises to develop and market medicines and vaccines worldwide. Merck plans to enhance the value of its medicines and vaccines through...

Words: 1954 - Pages: 8

Premium Essay

Merck Acquisition of Medco Study and Analysis

...Merck Acquisition of Medco Study and Analysis Abstract Corporate mergers and acquisitions (M&A) have become popular across the globe during the last two decades due to globalization, liberalization, technological developments, and competitive business environment (Fisher & Siburg, 2009). The synergistic gains from M&A may result from efficient management, economies of scale, profitable use of assets, exploitation of market power, and the use of complementary resources (Mitchell et al, 2004). Theoretically it is assumed that mergers improve the performance of the acquiring firm due to increased market share and synergy impact. This paper reviews the acquisition of Medco Medco Containment Services, Inc. (Medco) by Merck & Company (Merck) and cites reasons for acquisition of Medco. Merck's acquisition of Medco represents a $6.6 billion bet on where the future of the pharmaceutical industry lies (Nichols, 1994). In today's managed-care environment, Vagelos (CEO of Merck in 1993) argues, the company that best controls the information flow from doctor to patient to pharmacist to plan sponsor has the greatest chance of succeeding. Medco has information on 38 million patients, which allows Merck to learn a lot more about how its drugs are prescribed and used and, ultimately, how effective they are in fighting disease. Owning Medco can also help Merck increase its market share in an industry in which no company has more...

Words: 2407 - Pages: 10

Premium Essay

Pm587 Teampaper Pt1

...PM587 – Advanced Program Management March 23, 2012 BEFGS – Week 4 Background and Proposal Industry Background Over the last century, the life expectancy of an individual has increased from 47 in 1900 to 76 in 1997. (Moody, 1997) This increase in life expectancy is due to better living conditions, better care for the sick or disabled, and breakthroughs in the pharmaceutical industry. Pharmaceutical companies have been able to aid the pursuit of longevity and health through understanding the mechanics of the human body, disease, and disease treatment and prevention. Treatment and prevention comes in the form of new drugs and consumer products which have been developed over the last century and companies in this vertical expend significant resources on the research and development of them. The main objective in the industry is to improve the quality of life for everyone. There are three main types of pharmaceutical companies: large, small, and generic. Large pharmaceutical companies are established firms that have many approved drugs already on the market. Examples would be Merck, Bayer, Johnson & Johnson, and GlaxoSmithKline. These companies often have significant numbers of Research and Development (R&D) laboratories and manufacturing plants globally. In contrast, smaller pharmaceutical companies are usually more research focused, and often do not have any drugs on the market. Smaller companies in the pharmaceutical industry can also operate as contract manufacturers...

Words: 1871 - Pages: 8

Premium Essay

Ivey Cases Analysis Yuanan Baiyao

...Introduction Yunnan Baiyo Group (YB) develops traditional Chinese medicine. In 1902, Baiyo (originally Qu Huanzhang Panacea) was formulated by Qu Haunzhang (respected practitioner of Chinese Medicine) from an assortment of natural herbs in Yunnan Province. During the years, Yunnan Baiyao gained a great reputation in China for its ability to treat open wounds, muscular sprains, bruising and arthritis, and the ability to invigorate the blood circulation. This was effective in treating soldiers during warfare and it became a part of the first aid kid of the Chinese armed forces. Growth In 1996 Yunnan Baiyao Limited Co. and three other producers were integrated into Yunnan Baiyao Group Co. through joint shareholding. China became member of the WTO, which increased the competition landscape. In 2002 , Baiyao Da Yao Fang Ltd (a drugstore chain) was established and Wuding Planting Base was established to carry out the forward vertical integration. Industry players are adjusting to open market and multinationals were coming into play. Many of YB products had reached maturity and growth potential was limited in current state. To respond to current challenges YB established a series of strategies “one core and four growth areas”. The “one core” would focus on the YB headquarters and the three companies it had acquired, as well as the sales network. Symptoms In order to depict the problem for YB there were three issues. Firstly, it is evident YB has a growth issue...

Words: 5559 - Pages: 23

Premium Essay

Planning

...Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors within the country's economy. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. The professional knowledge, thoughts and innovative ideas of the pharmaceutical professionals working in this sector are the key factors for this development. Due to recent development of this sector it is exporting medicines to global market including European market. This sector is also providing 97% of the total medicine requirement of the local market. Leading pharmaceutical companies are expanding their business with the aim to expand export market. Recently few new industries have been established with high tech equipments and professionals which will enhance the strength of this sector. Reciprocating to the call of the days, Radiant started its journey in 2004 with a view to making further contributions to these promising sectors. With a team of more than 600 colleagues, our companies are engaged in manufacturing, importing, marketing and distributing of pharmaceutical, herbal, nutraceutical and diagnostic products. From the very inception, Radiant has been instrumental in promoting technology transfer through establishing collaborative relations with the internationally reputed companies. This is reflected in our license agreements with the pharmaceutical companies like F. Hoffmann-La Roche Limited, Switzerland and the leading innovative herbal drugs manufacturer...

Words: 2614 - Pages: 11

Free Essay

Marketing Strategy of Pfizer

...the latest products. Besides the brand boost, new products can help a company stay competitive in a tough market. If a company has the best product in a segment, they are likely to gain market share in that segment. * Other points to consider: * Lipitor is the first choice of drug for treatment of high cholesterol. * Lipid regulator market will continue to generate high revenues. * Pfizer, leading pharmaceutical company, most profitable * Pfizer has well respected name all over the world and has some of the top research, advertising, financial and marketing talent * Lipitor recommended by American hearth association. * High Cholesterol, which is a common problem across the globe is only likely to increase with rapidly aging population specially in the US and rise in obesity levels. Weaknesses * Co-marketing agreement for pfizer: * Co-marketing agreements can...

Words: 833 - Pages: 4

Premium Essay

Yb Case Study

...Group Case Study 1 Report HAS 6149 Group 3 Florida International University Background Information Yunnan Baiyao Group Co., Ltd. (YB) is a state-owned enterprise in China. Through more than a hundred-year history, Yunnan Baiyao had become a household brand in China for its unique traditional herbal medicines that were effective in the treatment of open wounds, fractures, contusions and strains. However, along with the rapid changes of the pharmaceutical industry in China and the maturity of YB’s products, they are reaching a bottleneck. In order to help YB to extend its life cycle and stabilize its profit, YB had to look for new growth areas. The options of product diversification and market diversification have risen. In this case study, our mission is to decide which option above is better for the development of YB based on our analysis. SWOT Analysis Strengths Long history and respected reputation in China and other Asian countries. Year 2012 is the 100 anniversary of YB, as a brand with 100 years history, YB is well-known in China, as well as in Singapore, Malaysia, Thailand, and Vietnam. For a long time till now, this respected brand always with the image of trustful, healthy, and organic. In 1996, Yunnan Baiyao Company integrated other three producers into a sole owner of Baiyao-Yunnan Baiyao Group Co. (YB). By this means, YB can strengthen its brand reputation and standardize the products’ quality. A diversified and vertically integrated player...

Words: 2496 - Pages: 10

Premium Essay

M&a Merck

...Merck & Medco You Decide Assignment Merck’s acquisition of Medco: Merger Analysis and Recommendation by Marzena Porebski . Table of Contents 1.0 INTRODUCTION 2 2.0 THE COMPANY OVERVIEW 3 2.1 Merck & Company 3 2.2 Medco Containment Services Inc. 5 2.3 The Companies Advantages 6 3.0 MERCK & MEDCO MERGER 7 3.1 Acquisition Details 7 3.2 Merger Analysis 7 4.0 CONCLUSION 11 5.0 APPENDIX 12 5.1 Financial Reports 12 5.2 Sales of Drugs and Prices 13 5.3 Merger and Acquisition Activity 14 5.4 Market Share 15 5.5 Additional Documents 15 6.0 References 15 1.0 INTRODUCTION Mergers and acquisitions occur because directors see benefits that could come from combining two or more businesses, which could improve the company’s overall financial performance. Mergers and related acquisitions have occurred in the United States in a series of waves over the last century or more, as can be seen on the chart in Appendix 5.3. Over time, mergers have become popular and in recent times, the growth has been steeper outside of the United States. One of many reasons why mergers occur is due to macroeconomic factors that contribute to a merger wave such as economic conditions, credit availability, industry shocks, government policy changes, competitive business environment, innovation, technological developments, or globalization (Thompson). Mergers and acquisitions can generate cost efficiency through economies of scale, can increase the revenue through gain in...

Words: 3006 - Pages: 13

Premium Essay

Merck & Medco You Decide Assignment

...Merck’s acquisition of Medco: Merger Analysis and Recommendation by Marzena Porebski . Table of Contents 1.0 INTRODUCTION 2 2.0 THE COMPANY OVERVIEW 3 2.1 Merck & Company 3 2.2 Medco Containment Services Inc. 5 2.3 The Companies Advantages 6 3.0 MERCK & MEDCO MERGER 7 3.1 Acquisition Details 7 3.2 Merger Analysis 7 4.0 CONCLUSION 11 5.0 APPENDIX 12 5.1 Financial Reports 12 5.2 Sales of Drugs and Prices 13 5.3 Merger and Acquisition Activity 14 5.4 Market Share 15 5.5 Additional Documents 15 6.0 References 15 1.0 INTRODUCTION Mergers and acquisitions occur because directors see benefits that could come from combining two or more businesses, which could improve the company’s overall financial performance. Mergers and related acquisitions have occurred in the United States in a series of waves over the last century or more, as can be seen on the chart in Appendix 5.3. Over time, mergers have become popular and in recent times, the growth has been steeper outside of the United States. One of many reasons why mergers occur is due to macroeconomic factors that contribute to a merger wave such as economic conditions, credit availability, industry shocks, government policy changes, competitive business environment, innovation, technological developments, or globalization (Thompson). Mergers and acquisitions can generate cost efficiency through economies of scale, can increase the revenue through gain in market...

Words: 3020 - Pages: 13

Free Essay

Learning Team Reflection

...submitted to the FDA with a full report. This can be an expensive and lengthy process, so then congress created an easier path for generic drugs to be issued to the public. In 1984 the Hatch-Waxman Act was created which allots for generic drugs to be approved for use without so many provisions. The drug is a mirror image of the name brand drug. The Supreme Court ruled in favor of Mutual Pharmaceutical reversing Bartlett’s initial argument of failure-to-warn and design-defect claims. The courts denied her failure-to-warn claim because she did not read the box nor label. The other claim of design-defect was found to stand and held Mutual liable for $21 million in damages. Mutual did appeal. Analysis The case of Mutual Pharmaceutical Co. v. Bartlett, exhibits the conflicts that may arise between Federal and State Laws in regards to liability of generic drug manufactures. Mrs. Karen Barlett took a generic...

Words: 705 - Pages: 3

Free Essay

Korea Pharmaceutical Directory

...status that can be utilized by companies who are making commitment for the development of pharmaceutical industry. 2. Targets and Contents of Directory Book 1) Targets for directory book •Korean Pharmaceutical companies: 81 companies. 2) Contents of directory book •Investigation items 3. Method and Way for Utilization 1) Method □ Ways to select investigation targets and to promote them were developed through consultation from consultation committees and domestic pharmaceutical companies (including unlisted ones) ◦Investigated based on basic data involving scale of sales, number of employees and scale of production, export and import ◦Information was also investigated that companies which got into the business late can bench mark in marketing part such as strategies of brand making, new product development and distribution □ Information on current status of R&D collected through email, phone consultation and...

Words: 30709 - Pages: 123

Free Essay

Aleve Market Plan

...Aleve Market Plan XXXXXXXXX BUS 620 Managerial Marketing XXXXXXXXX xxxxxx Aleve Market Plan * Executive Summary of Marketing Plan Aleve All day strong. All day long Bayer Consumer Care manufactures parent company Bayer's line of over-the-counter drugs and nutritional supplements.  One of the largest manufacturers of OTC drugs in the world, the division has production facilities in Europe, North America, Latin America, and Asia and sells its products in over 100 countries at pharmacies and other retail outlets (Law, Bayer AG, 2012). This market plan is to establish how Bayer Consumer Care, the manufacturers of Aleve intend to capitalize on the nonsteroidal anti-inflammatory drugs (NSAIDs) market as drugmakers scramble to grab Vioxx's and Bextra’s multi-billion-dollar share of the arthritis and pain-relief market. Aleve is used to treat pain or inflammation caused by conditions such as arthritis, ankylosing spondylitis, tendinitis, bursitis, gout, or menstrual cramps (Cerner Multum, Inc., 1996-2012). * Company Overview Take two Aspirin ... and maybe some Alka-Seltzer antacid and One-a-Day vitamins to be on the safe side. Bayer Consumer Care manufactures parent company Bayer's line of over-the-counter drugs and nutritional supplements. Its products include analgesics, cough and cold medicines, dermatology care, and gastrointestinal remedies. One of the largest manufacturers of OTC drugs in the world, the division has production facilities in Europe, North...

Words: 1771 - Pages: 8